Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A10BB12	GLYPRIDE	G	Glimepiride - 2mg	2mg	Tablet	403,153 L.L
A10BB12	GLIM	G	Glimepiride - 3mg	3mg	Tablet	533,505 L.L
A10BB12	GLUMYL 3	G	Glimepiride - 3mg	3mg	Tablet	511,940 L.L
A10BB12	GLYPRIDE	G	Glimepiride - 3mg	3mg	Tablet	571,133 L.L
A10BB12	GLIM	G	Glimepiride - 4mg	4mg	Tablet	628,918 L.L
A10BB12	GLUMYL 4	G	Glimepiride - 4mg	4mg	Tablet	317,403 L.L
A10BB12	GLYPRIDE	G	Glimepiride - 4mg	4mg	Tablet	657,139 L.L
H04AA01	GLUCAGEN	BioTech	Glucagon HCl - 1mg	1mg	Injectable powder for solution+diluent	1,343,444 L.L
B05CX01	GLUCOSE INJ.	G	Glucose - 10g/20ml	50%	Injectable solution	5,038,066 L.L
B05CX01	GLUCOSE INJ.	G	Glucose - 6g/20ml	30%	Injectable solution	5,157,668 L.L
D02AX	GLYCERINE	G	Glycerol -		Liquid	163,821 L.L
A03AB02	GLYCOPYRROLATE	B	Glycopyronium Bromide - 0.2mg/ml	0.2mg/ml	Injectable solution	7,238,185 L.L
A04AA02	GRANI-DENK	G	Granisetron - 1mg/ml	1mg/ml	Injectable concentrate for solution	893,655 L.L
A04AA02	GRANI-DENK	G	Granisetron - 3mg/3ml	3mg/3ml	Injectable concentrate for solution	1,679,803 L.L
D01BA01	GRISEOFULVIN	G	Griseofulvin - 500mg	500mg	Tablet, scored	575,933 L.L
C05CA54	GINKOR FORT	B	Heptaminol HCl - 0.300g, Troxerutine - 0.300g, Ginkgo biloba extract - 0.014g		Capsule	681,328 L.L
J06BA02	GAMUNEX-C	BioHuman	Human normal immunoglobulin G - 10%	10%	Injectable solution	39,990,287 L.L
L01EA01	GLIVEC	B	Imatinib (mesylate) - 100mg	100mg	Tablet, film coated	50,531,993 L.L
L01EA01	GLIMATINIB BENTA	G	Imatinib (mesylate) - 100mg	100mg	Tablet, film coated	17,619,185 L.L
L01EA01	GLIMATINIB BENTA	G	Imatinib (mesylate) - 100mg	100mg	Tablet, film coated	43,103,200 L.L
L01EA01	GLIMATINIB BENTA 400	G	Imatinib (mesylate) - 400mg	400mg	Tablet, film coated	38,254,090 L.L
L01EA01	GLIMATINIB BENTA 400	G	Imatinib (mesylate) - 400mg	400mg	Tablet, film coated	L.L
D06BB10	GENIMOD	G	Imiquimod - 5%	5%	Cream	2,268,406 L.L
J07BB01	GC FLU QUADRIVALENT INFLUENZA VACCINE	G	Influenza vaccine inactivated (split virion, purified, quadrivalent) (H1N1, H3N2,BVR-26, B/Phuket/3073/2013) - 15mcg/4strains/0.5ml		Injectable suspension	791,523 L.L
A10AE04	GLARTUS	BioTech	Insulin glargine - 100U/ml	100U/ml	Injectable solution	1,346,530 L.L
C09CA04	GIZLAN	G	Irbesartan - 150mg	150mg	Tablet, film coated	748,520 L.L
C09DA04	GIZLAN-PLUS	G	Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	395,090 L.L
C09CA04	GIZLAN	G	Irbesartan - 300mg	300mg	Tablet, film coated	768,678 L.L
C09DA04	GIZLAN-PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	395,090 L.L
C09DA04	GIZLAN-PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 25mg		Tablet, film coated	768,678 L.L